Dipna Pharmachem Ltd
₹0.00▲ +0.00 (+0.00%)
543594·NSE·Healthcare
Market Cap
13.70 Cr
PE Ratio
5.20
Volume
—
Day High - Low
—
52W High-Low
25.00 - 4.94
₹0.00▲ +0.00 (+0.00%)
Market Cap13.70 Cr
PE Ratio5.20
Volume—
Day High - Low—
52W High-Low25.00 - 4.94
Dipna Pharmachem Ltd (543594): company summary
Dipna Pharmachem Ltd (543594) is a micro-cap Healthcare company valued at ₹14 crore operating in Pharmaceuticals on the NSE and BSE.
Dipna Pharmachem Ltd (543594) is a micro-cap Healthcare company valued at ₹14 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing steadily at 8.9% a year over three years; profit grew 37.9% a year, ahead of revenue — margins are expanding. Return on equity is 5.2%.
- Valuation multiples
- The stock trades at 5.2 times earnings, a discount to the Healthcare median of 32.5, 0.22 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
6.0/10
Fair
Fair Value
Sign in to see
ROE
5.22%
Weak
P/E
5.20x
Cheap
Debt / Equity
0.21
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹4.94
₹25.00
DocStoX take
Supported by valuation (9.0) and growth (8.5), but held back by quality (2.0). Valuation looks strong at 9.0, but that is offset by quality at 2.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence6.0
/10
Fair
Quality
Weak
ROE 5.2%
Valuation
Cheap
P/E 5.2×
Growth
Strong
Revenue +33.0% 5Y CAGR
Risk
Moderate
D/E 0.21
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹14 Cr
52W High / Low
₹25 / ₹5
Dividend Yield
0.00%
Promoter Holding
9.13%
EPS (TTM)
₹0.40
Book Value
₹23.70
Key highlights
- Profit compounding 38% a year
- Revenue compounding 33% a year
- Low leverage — D/E 0.21
- Quality is weak (2.0/10)
- Small ₹14 cr company — thinner liquidity
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Dipna Pharmachem Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Dipna Pharmachem Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Dipna Pharmachem Ltd with peers
Related tools & concepts
Value Dipna Pharmachem Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing